CAS 13058-67-8: Lucensomycin
Description:Lucensomycin is a naturally occurring antibiotic that belongs to the class of compounds known as aminoglycosides. It is produced by certain strains of the bacterium *Micromonospora* and exhibits antibacterial properties primarily against Gram-positive bacteria. The chemical structure of lucensomycin features a complex arrangement of sugar moieties and an amino group, which contribute to its biological activity. This compound functions by inhibiting protein synthesis in bacteria, thereby preventing their growth and replication. Lucensomycin has garnered interest in pharmaceutical research due to its potential therapeutic applications, particularly in treating infections caused by resistant bacterial strains. Its unique mechanism of action and structural characteristics make it a subject of study for developing new antibiotics. However, like many antibiotics, the emergence of resistance poses challenges to its clinical use, necessitating ongoing research to understand its efficacy and safety profile in various medical contexts.
Formula:C36H53NO13
InChI:InChI=1S/C36H53NO13/c1-3-4-12-23-13-10-8-6-5-7-9-11-14-24(48-35-33(42)31(37)32(41)21(2)46-35)18-28-30(34(43)44)25(39)20-36(45,50-28)19-22(38)17-27-26(49-27)15-16-29(40)47-23/h5-11,14-16,21-28,30-33,35,38-39,41-42,45H,3-4,12-13,17-20,37H2,1-2H3,(H,43,44)/b6-5+,9-7+,10-8+,14-11+,16-15+/t21-,22+,23?,24+,25+,26-,27-,28+,30-,31+,32-,33+,35+,36-/m1/s1
InChI key:InChIKey=MUAOHYJGHYFDSA-YZMLMZOASA-N
SMILES:O=C(O)C1C(O)CC2(O)OC1CC(OC3OC(C)C(O)C(N)C3O)C=CC=CC=CC=CCC(OC(=O)C=CC4OC4CC(O)C2)CCCC
- Synonyms:
- (1R,3S,5R,7R,8E,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-β-<span class="text-smallcaps">D</span>-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- (8E)-22-[(3-amino-3,6-dideoxy-beta-D-glycero-hexopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- 6,11,28-Trioxatricyclo(22.3.1.05,7)octacowq-8,14,16,18,20-pentaene-25-carboxylic acid, 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-β-<span class="text-smallcaps">D</span>-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.0<sup>5,7</sup>]octacosane, lucensomycin deriv.
- Antibiotic 1163 F.I.
- Antibiotic FI 1163
- Antibiotic obtained from cultures of Streptomyces lucensis, or the same substance produced by any other means
- Etruscomicina
- Etruscomycin
- See more synonyms
- Fi 1163
- Leucensomycin
- Lucensomycin
- Nsc 143257
- Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo(33.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
- 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-
- 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosane, lucensomycin deriv.
- (1R,3S,5R,7R,8E,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-12-butyl-1,3,26-trihydroxy-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Lucimycin REF: TM-T25762CAS: 13058-67-8 | - - - | 1,444.00 € | Fri 28 Mar 25 |
![]() | Lucimycin REF: 3D-FL177686CAS: 13058-67-8 | Min. 95% | To inquire | Mon 07 Apr 25 |

Lucimycin
Ref: TM-T25762
25mg | 1,444.00 € |

Lucimycin
Ref: 3D-FL177686
Undefined size | To inquire |